Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Editor’s Picks: Notable Gray Sheet Stories From 2013

This article was originally published in The Gray Sheet

Executive Summary

2013 was a challenging year on some fronts for industry, and the impasses in Congress did not help. But there were some positive policy signals from FDA. There were also some very significant rules finalized – for the unique device identification and the Physician Payment Sunshine Act programs – that signal the need for important implementation efforts in 2014. Here are some of last year’s most important stories from “The Gray Sheet,” based on web hits and editor prerogative.

Related Content


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts